
Cannabis Testing Market Report 2026
Global Outlook – By Test Type (Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing, Other Test Types ), By Technology (Chromatography, Spectroscopy, Other Technologies), By End User (Testing Laboratories, Research Institutes, Other End Users) - Market Size, Trends, And Global Forecast 2026-2035
Cannabis Testing Market Overview
• Cannabis Testing market size has reached to $3.56 billion in 2025 • Expected to grow to $8.72 billion in 2030 at a compound annual growth rate (CAGR) of 19.6% • Growth Driver: Increase In Neurological Conditions Are Anticipated To Fuel The Cannabis Testing Market • Market Trend: Groundbreaking Test To Address The Need For Accurate Impairment Assessment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Cannabis Testing Market?
Cannabis refers to the analysis of an individual sample of cannabis that is examined to determine tetrahydrocannabinol, cannabidiol, and terpene levels, as well as impurities such as residual solvents, mold, pests, disease, or pesticide residue. The cannabis test is used to relieve stress, muscle pain, nausea, and vomiting. The main test types for cannabis testing are potency testing, pesticide screening, residual solvent screening, heavy metal testing, terpene testing, mycotoxin testing, and others. Instruments refers to the instruments used to test cannabis products. The different technologies include chromatography, spectroscopy, and others and involve several portability types, such as stand-alone, handheld devices. These are employed in testing laboratories, drug manufacturers, research institutes, and other end users.
What Is The Cannabis Testing Market Size and Share 2026?
The cannabis testing market size has grown rapidly in recent years. It will grow from $3.56 billion in 2025 to $4.26 billion in 2026 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to expansion of legalized cannabis markets, increasing regulatory safety requirements, growth of commercial cannabis production, adoption of laboratory-based quality testing, rising need for consumer safety assurance.What Is The Cannabis Testing Market Growth Forecast?
The cannabis testing market size is expected to see rapid growth in the next few years. It will grow to $8.72 billion in 2030 at a compound annual growth rate (CAGR) of 19.6%. The growth in the forecast period can be attributed to increasing investments in rapid testing technologies, rising demand for real-time potency analysis, expansion of standardized testing regulations, growing adoption of handheld testing devices, increasing integration of digital lab management systems. Major trends in the forecast period include increasing demand for comprehensive cannabis testing services, rising adoption of advanced chromatography techniques, growing focus on regulatory compliance testing, expansion of portable testing devices, enhanced data accuracy and traceability.Global Cannabis Testing Market Segmentation
1) By Test Type: Potency Testing, Pesticide Screening, Residual Solvent Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing, Other Test Types 2) By Technology: Chromatography, Spectroscopy, Other Technologies 3) By End User: Testing Laboratories, Research Institutes, Other End Users Subsegments: 1) By Potency Testing: THC Testing, CBD Testing, Other Cannabinoids Testing 2) By Pesticide Screening: Herbicide Testing, Insecticide Testing, Fungicide Testing 3) By Residual Solvent Screening: Solvent Class Testing, Total Residual Solvent Analysis 4) By Heavy Metal Testing: Lead Testing, Arsenic Testing, Cadmium Testing, Mercury Testing 5) By Terpene Testing: Major Terpene Profile Analysis, Minor Terpene Analysis 6) By Mycotoxin Testing: Aflatoxin Testing, Ochratoxin Testing 7) By Other Test Types: Microbial Testing, Moisture Content Testing, Foreign Material TestingWhat Is The Driver Of The Cannabis Testing Market?
The increase in neurological conditions is expected to propel the growth of the cannabis testing market going forward. Neurological conditions refer to disorders affecting the nervous system, including the brain, spinal cord, and peripheral nerves, leading to various cognitive, motor, and sensory impairments. Cannabis testing is used in neurological conditions for analyzing cannabinoids to explore potential therapeutic benefits and effects on symptoms including pain, spasticity, and seizures. For instance, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, over 40% of the global population currently suffered from some neurological condition, and this burden is projected to nearly double by 2050. Therefore, the increase in neurological conditions is driving the cannabis testing industry.Key Players In The Global Cannabis Testing Market
Major companies operating in the cannabis testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, SGS Canada Inc., Eurofins Scientific SE, Agilent Technologies Inc., Sartorius AG, PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, AB Sciex LLC, LGC Limited, Tentamus Group, Phenomenex Inc., Saskatchewan Research Council (SRC), Restek Corporation, SC Laboratories, Anresco Labs, Praxis Labs, Accelerated Technology Laboratories Inc., GreenLeaf Lab, ACT Laboratories, PharmLabs LLC, Abko Labs, BelCosta Labs, Medicinal Genomics, CW Analytical Laboratories Inc., DigiPath Inc., CDX Analytics, Steep Hill Halent Laboratories Inc.Global Cannabis Testing Market Trends and Insights
Major companies in the cannabis testing market are focused on developing groundbreaking tests, such as roadside cannabis tests, to address the need for accurate impairment assessment and to gain a competitive edge in the market. A roadside cannabis test is a diagnostic method, utilizing neurodiagnostic to assess recent cannabis use and associated impairment. For instance, in April 2023, Oculogica, a US-based medical device manufacturing company, launched OcuPro, a roadside cannabis test utilizing neurodiagnostic to assess recent cannabis use and associated impairment. The device, piloted in several Missouri police departments, records and analyzes eye-pupil characteristics, distinguishing between recent use within 60-90 minutes and use over several hours. Unlike conventional tests relying on THC analysis from body samples, OcuPro directly addresses the need for a scientifically validated test for impairment from recent cannabis use, crucial for enforcing laws against driving under the influence.What Are Latest Mergers And Acquisitions In The Cannabis Testing Market?
In May 2023, ACT Laboratories, a US-based cannabis and hemp testing network acquired Green Scientific Labs for an undisclosed amount. This acquisition was aimed to diversify and expand its ready-to-drink (RTD) portfolio. Green Scientific Labs is a US-based hemp, cannabis and marijuana testing laboratory.Regional Outlook
North America was the largest region in the cannabis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Cannabis Testing Market?
The cannabis testing market includes revenues earned by entities by cannabinoid profile & potency analysis, heavy metal screening, mycotoxin screening, molds & mildews, pesticides & herbicides and residual solvents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Cannabis Testing Market Report 2026?
The cannabis testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Cannabis Testing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.26 billion |
| Revenue Forecast In 2035 | $8.72 billion |
| Growth Rate | CAGR of 19.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Test Type, Technology, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, SGS Canada Inc., Eurofins Scientific SE, Agilent Technologies Inc., Sartorius AG, PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, AB Sciex LLC, LGC Limited, Tentamus Group, Phenomenex Inc., Saskatchewan Research Council (SRC), Restek Corporation, SC Laboratories, Anresco Labs, Praxis Labs, Accelerated Technology Laboratories Inc., GreenLeaf Lab, ACT Laboratories, PharmLabs LLC, Abko Labs, BelCosta Labs, Medicinal Genomics, CW Analytical Laboratories Inc., DigiPath Inc., CDX Analytics, Steep Hill Halent Laboratories Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
